U of M study identifies medication that helps people with obsessive-compulsive disorderJuly 20, 2007Researchers at the University of Minnesota have found that a drug originally developed to fight tuberculosis may help people with obsessive-compulsive disorder make more progress in therapy sessions. Now they want to see if this drug could have a similar effect on people who want to quit smoking. The research, led by Matt Kushner, Ph.D., was published in the online edition of Biological Psychiatry, and will appear in an upcoming print edition. Kushner's collaborators include Suck Won Kim, M.D., and Christopher Donahue, Ph.D.
The drug, D-Cycloserine, is believed to help accelerate "extinction learning." On a basic level, people associate positive or negative feelings with various cues from the external world. Behavioral therapy attempts to help the person disassociate problematic reactions that are either positive (e.g., craving to use an addictive substance) or negative (e.g., fear of some catastrophic outcome) from the cues that trigger these feelings. "This offers another therapeutic approach where we can attempt to manipulate the memory process and the brain's reward/punishment system so people can learn healthier responses to various cues," Kushner said. For example, a person with OCD may have negative feelings before or after touching a doorknob. In psychotherapy, the person would work on disassociating the negative feeling with the external cue of seeing or touching a doorknob. In this research project, investigators separated the people with OCD into two groups. One group received the drug and another received a placebo several hours before psychotherapy. Kushner found that those who took the drug made progress in therapy more quickly and were less likely to quit therapy compared with the placebo group. The research subjects who took the drug reported feeling less distress or anxiety due to their obsessions or compulsions. The drug seemed to be most effective in the first few therapy sessions. Over time, people in the placebo group could catch up in terms of therapy goals, but more study participants in the placebo group dropped out of therapy. "The dropout rate decreased dramatically," Kushner said. "Typically about 20 to 30 percent of people with OCD drop out of therapy. Only 7 percent of people who took the D-Cycloserine dropped out." Kushner said that the drug will not work by itself; it must be done in conjunction with therapy to be effective. Kushner and his team are now studying how the drug will effect smokers' who want to quit, and they are seeking smokers to participate in a research study. "People who smoke have positive feelings from the drug effects of nicotine associated with exposure to cues of smoking, such as seeing a pack of cigarettes, lighting up, or actually smoking," Kushner said. "This research project investigates whether or not we will see a similar extinction learning effect in people who smoke." Study participants will be given nicotine-extracted cigarettes to smoke, and similar to the previous study, one group will receive the drug, another the placebo, prior to therapy sessions. Participants will attend sessions once per week for four weeks, and they will be asked to smoke only the nicotine-extracted cigarettes in between the sessions. University of Minnesota | |||||||||||||||||||||
|
Related Obsessive-compulsive Disorder Current Events and Obsessive-compulsive Disorder News Articles Novel imaging technique reveals brain abnormalities that may play key role in ADHD A study published today in the online advance edition of The American Journal of Psychiatry for the first time reveals shape differences in the brains of children with ADHD, which could help pinpoint the specific neural circuits involved in the disorder. APA task force recommends dissemination of evidence-based practice An estimated 15 million American children are diagnosed with a mental disorder, but only about a quarter of them are getting appropriate treatment based on scientific evidence. D-cycloserine may improve behavioral therapy treatment for anxiety Anxiety is a normal human response to stress, but in some, it can develop into a disabling disorder of excessive and irrational fears, such as obsessive-compulsive disorder, panic disorder, or posttraumatic stress disorder. Effective treatments are available and can involve either behavioral therapy or medications. Young children with OCD benefit from family-based treatment Although children as young as 5 can be diagnosed with obsessive-compulsive disorder (OCD), few research studies have looked at treatments specifically geared toward young children with this disorder. Rapid effects of intensive therapy seen in brains of patients with OCD In a study that may significantly advance the understanding of how cognitive-behavioral therapy affects the brain, researchers have shown that significant changes in activity in certain regions of the brain can be produced with as little as four weeks of daily therapy in patients with obsessive-compulsive disorder (OCD). Sleep chemical central to effectiveness of deep brain stimulation A brain chemical that makes us sleepy also appears to play a central role in the success of deep brain stimulation to ease symptoms in patients with Parkinson's disease and other brain disorders. The surprising finding is outlined in a paper published online Dec. 23 in Nature Medicine. Child mental health experts issue psychiatric medication treatment guidelines for preschoolers The number of preschool-age children being treated with stimulants, antidepressants and other psychiatric drugs is on the rise, despite limited research and a lack of clinical practice guidelines. Anti-depressant drugs can double risk of gastrointestinal bleeding New research shows that selective serotonin reuptake inhibitors (SSRIs), a group of drugs commonly used to treat depression, may double the risk of gastrointestinal bleeding. Mice provide important clues to obsessive-compulsive disorder Mice born without a key brain protein compulsively groom their faces until they bleed and are afraid to venture out of the corner of their cages. Gene triggers obsessive compulsive disorder-like syndrome in mice Using genetic engineering, researchers have created an obsessive-compulsive disorder (OCD) - like set of behaviors in mice and reversed them with antidepressants and genetic targeting of a key brain circuit. More Obsessive-compulsive Disorder Current Events and Obsessive-compulsive Disorder News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||